Bridget Batcheller, MSW, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 10a Merrimac Sq, Merrimac, MA 01860 Phone: 978-998-5663 |
Denise Guida Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 57 W Shore Rd, Merrimac, MA 01860 Phone: 978-346-7655 |
Ms. Maureen Kemmerer, LICSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 10 Little Pond Rd, Merrimac, MA 01860 Phone: 978-618-8229 |
Hannah Friedrich Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 30 Bear Hill Rd, Merrimac, MA 01860 Phone: 605-639-0147 |
Mr. Christopher William Judkins, LICSW Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 3 Harriman Rd, Merrimac, MA 01860 Phone: 978-417-9456 |
Rebecca Izsak, LICSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1 Brush Hill Rd, Merrimac, MA 01860 Phone: 617-827-4053 |
News Archive
People generally think of stress and anxiety as negative concepts, but while both stress and anxiety can reach unhealthy levels, psychologists have long known that both are unavoidable - and that they often play a helpful, not harmful, role in our daily lives, according to a presentation at the annual convention of the American Psychological Association.
Perrigo Company today announced that it has received final approval for the generic version of Sanctura XR. Perrigo had previously prevailed in litigation at both the district and appellate levels. The product has begun shipping immediately.
Consumer Watchdog said Massachusetts' rejection today of excessive and unreasonable health insurance rate increases shows the need for effective "prior approval" rate regulation in every state to ensure that health insurers charge fair prices under national health reform legislation, which is modeled on Massachusetts' mandatory health insurance law. Massachusetts regulators recently adopted emergency prior approval regulations in anticipation of large insurance premium increases.
MorphoSys Obtains Additional U.S. Patents on Antibody Technologies MorphoSys AG (Frankfurt Stock Exchange: MOR; Prime Standard Segment) announced today that the U.S. Patent & Trademark Office has granted two new patents, which further strengthen the Company's IP portfolio.
Bacterial infections really stink. And that could be the key to a fast diagnosis.
› Verified 4 days ago